Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 3;113(9):1275-81.
doi: 10.1038/bjc.2015.357. Epub 2015 Oct 20.

The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma

Anna Wilkins  1   2   3 , Andrew Furness  1   2 , Richard W Corbett  4 , Adam Bloomfield  1 , Nuria Porta  3 , Stephen Morris  5 , Zohra Ali  1   2 , James Larkin  1   3 , Kevin Harrington  1   2
Affiliations

The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma

Anna Wilkins et al. Br J Cancer. .

Abstract

Background: The melanoma-specific graded prognostic assessment (msGPA) assigns patients with brain metastases from malignant melanoma to 1 of 4 prognostic groups. It was largely derived using clinical data from patients treated in the era that preceded the development of newer therapies such as BRAF, MEK and immune checkpoint inhibitors. Therefore, its current relevance to patients diagnosed with brain metastases from malignant melanoma is unclear. This study is an external validation of the msGPA in two temporally distinct British populations.

Methods: Performance of the msGPA was assessed in Cohort I (1997-2008, n=231) and Cohort II (2008-2013, n=162) using Kaplan-Meier methods and Harrell's c-index of concordance. Cox regression was used to explore additional factors that may have prognostic relevance.

Results: The msGPA does not perform well as a prognostic score outside of the derivation cohort, with suboptimal statistical calibration and discrimination, particularly in those patients with an intermediate prognosis. Extra-cerebral metastases, leptomeningeal disease, age and potential use of novel targeted agents after brain metastases are diagnosed, should be incorporated into future prognostic models.

Conclusions: An improved prognostic score is required to underpin high-quality randomised controlled trials in an area with a wide disparity in clinical care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival outcomes for patients with brain metastases from melanoma. (A and B) Kaplan–Meier curves to show msGPA for Cohort I (1997–2008) and Cohort II (2008–2013). Abbreviation: msGPA=melanoma-specific graded prognostic assessment.
Figure 2
Figure 2
Kaplan–Meier curves to show survival according to BRAF status and treatment with BRAF inhibitors (BRAFi) in Cohort II.
See this image and copyright information in PMC

References

    1. Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I (2004) Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiotherap Oncol 71(3): 259–265. - PubMed
    1. Dummer R, Goldinger SM, Turtschi CP, Eggmann NB, Michielin O, Mitchell L, Veronese L, Hilfiker PR, Felderer L, Rinderknecht JD (2014) Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study. Eur J Cancer 50(3): 611–621. - PubMed
    1. Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem A, Heese O, Koelbl O, Garbe C, Schadendorf D Dermatologic Cooperative Oncology G, the National Interdisciplinary Working Group on M (2011) Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 117(8): 1697–1703. - PubMed
    1. Fisher R, Larkin J (2012) Treatment of brain metastases in patients with melanoma. Lancet Oncol 13(5): 434–435. - PubMed
    1. Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4): 1001–1006. - PubMed

Publication types